# Brain Imaging Study in Subjects With Alzheimer Disease in Comparison to Healthy Subjects

> **NCT00870519** · PHASE1 · TERMINATED · sponsor: **Institute for Neurodegenerative Disorders** · enrollment: 2 (actual)

## Conditions studied

- Alzheimer's Disease

## Interventions

- **DRUG:** I-123-MNI-168
- **DRUG:** 123-I MNI-168

## Key facts

- **NCT ID:** NCT00870519
- **Lead sponsor:** Institute for Neurodegenerative Disorders
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2009-01
- **Primary completion:** 2010-12
- **Final completion:** 2010-12
- **Target enrollment:** 2 (ACTUAL)
- **Why stopped:** Assessment of data shows inadequate brain uptake, suggesting the tracer is inadequate as an imaging biomarker of brain amyloid.
- **Last updated:** 2019-04-03


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00870519

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00870519, "Brain Imaging Study in Subjects With Alzheimer Disease in Comparison to Healthy Subjects". Retrieved via AI Analytics 2026-05-25 from https://api.ai-analytics.org/clinical/NCT00870519. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*